Bluejay Diagnostics Inc. Gains 26.5%

Mon, May 02, 2022 at 05:35 PM

Bluejay Diagnostics Inc. (BJDX:NASDAQ) soared at $1.48, a gain of 26.5%. On Fri, Apr 29, 2022, BJDX:NASDAQ touched a New 2-Week High of $1.17. The stock appeared on our News Catalysts scanner on Wed, Apr 20, 2022 at 05:56 PM in the 'EARNINGS' category. From Mon, Apr 18, 2022, the stock recorded 66.67% Up Days and 70.00% Green Days

About Bluejay Diagnostics Inc. (BJDX:NASDAQ)

Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide...

Top 10 Gainers:

Better Therapeutics Inc. (BTTX:NASDAQ), 120.39%
SoundHound AI Inc. (SOUN:NASDAQ), 68.46%
Forge Global Holdings Inc. (FRGE:NYSE), 44.34%
Redbox Entertainment Inc. (RDBX:NASDAQ), 42.64%
SOS Limited American Depositary Shares (SOS:NYSE), 39.74%
Blue Apron Holdings, Inc. (APRN:NYSE), 33.77%
Bluejay Diagnostics Inc. (BJDX:NASDAQ), 26.5%
Jasper Therapeutics Inc. (JSPR:NASDAQ), 23.61%
MICT, Inc. (MICT:NASDAQ), 23.19%
Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 23.05%